Malignant Choroid Neoplasm — Trials

Malignant Choroid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Aura Biosciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06007690	A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma(CoMpass)	active not recruiting	Phase 3	108	Aura BiosciencesINDUSTRY	14	Jul 31, 2026	clinicaltrials
NCT00680225	Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma	completed	Phase 3	10	New England Retina AssociatesOTHER	1